JENNIFER LYNCH: Open Payments
NPI 1740663038 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,890 in 149 payments from 36 companies in 2025. Trend: 2023 $2,043 · 2024 $2,104 · 2025 $2,890
Food & beverage: $2,740Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $497 |
| Amgen Inc. | 15 | $262 |
| Teva Pharmaceuticals USA, Inc. | 7 | $177 |
| Abbott Laboratories | 9 | $159 |
| Novo Nordisk Inc | 7 | $153 |
| Biogen, Inc. | 1 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $148 |
| Alnylam Pharmaceuticals Inc. | 2 | $147 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Lundbeck LLC | 4 | $91 |
Products named: VRAYLAR, UZEDY, FREESTYLE LIBRE 3, TYSABRI, CAPLYTA, AMVUTTRA, REXULTI, OTEZLA.
Industry payments across SC — which companies pay providers there.
